Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 2,166 shares at $80.05 ($173K) on 2025-01-07, disclosed to the SEC on 2025-01-10.
Scheduled sale ($173k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.05 | 1,083 | $87K | 50.0% |
| 2 | $80.05 | 1,083 | $87K | 50.0% |
| Total | $80.05 avg | 2,166 | $173K | 100% |
| Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |
| TMDX | SELL | 2024-10-03 | $637K | — | Filing → |